Literature DB >> 27799157

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Aung Ko Win1, Mark A Jenkins1, James G Dowty1, Antonis C Antoniou2, Andrew Lee2, Graham G Giles1,3, Daniel D Buchanan1,4, Mark Clendenning4, Christophe Rosty5, Dennis J Ahnen6, Stephen N Thibodeau7, Graham Casey8, Steven Gallinger9, Loïc Le Marchand10, Robert W Haile11, John D Potter12,13,14, Yingye Zheng12,13, Noralane M Lindor15, Polly A Newcomb12,13, John L Hopper1, Robert J MacInnis16,3.   

Abstract

Background: Although high-risk mutations in identified major susceptibility genes (DNA mismatch repair genes and MUTYH) account for some familial aggregation of colorectal cancer, their population prevalence and the causes of the remaining familial aggregation are not known.
Methods: We studied the families of 5,744 colorectal cancer cases (probands) recruited from population cancer registries in the United States, Canada, and Australia and screened probands for mutations in mismatch repair genes and MUTYH We conducted modified segregation analyses using the cancer history of first-degree relatives, conditional on the proband's age at diagnosis. We estimated the prevalence of mutations in the identified genes, the prevalence of HR for unidentified major gene mutations, and the variance of the residual polygenic component.
Results: We estimated that 1 in 279 of the population carry mutations in mismatch repair genes (MLH1 = 1 in 1,946, MSH2 = 1 in 2,841, MSH6 = 1 in 758, PMS2 = 1 in 714), 1 in 45 carry mutations in MUTYH, and 1 in 504 carry mutations associated with an average 31-fold increased risk of colorectal cancer in unidentified major genes. The estimated polygenic variance was reduced by 30% to 50% after allowing for unidentified major genes and decreased from 3.3 for age <40 years to 0.5 for age ≥70 years (equivalent to sibling relative risks of 5.1 to 1.3, respectively).Conclusions: Unidentified major genes might explain one third to one half of the missing heritability of colorectal cancer.Impact: Our findings could aid gene discovery and development of better colorectal cancer risk prediction models. Cancer Epidemiol Biomarkers Prev; 26(3); 404-12. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27799157      PMCID: PMC5336409          DOI: 10.1158/1055-9965.EPI-16-0693

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases.

Authors:  Kandelaria Rumilla; Karen V Schowalter; Noralane M Lindor; Brittany C Thomas; Kara A Mensink; Steven Gallinger; Spring Holter; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; Tiffany I Long; Daniel J Weisenberger; Robert W Haile; Graham Casey; Peter W Laird; Loic Le Marchand; Stephen N Thibodeau
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

2.  The search for unaffected individuals with Lynch syndrome: do the ends justify the means?

Authors:  Heather Hampel; Albert de la Chapelle
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

3.  After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.

Authors:  Mark A Jenkins; Laura Baglietto; Gillian S Dite; Damien J Jolley; Melissa C Southey; Jonathan Whitty; Leeanne J Mead; D James B St John; Finlay A Macrae; D Timothy Bishop; Deon J Venter; Graham G Giles; John L Hopper
Journal:  Int J Cancer       Date:  2002-11-10       Impact factor: 7.396

4.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

Review 5.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

6.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

Authors:  Marietta E Kovacs; Janos Papp; Zoltan Szentirmay; Szabolcs Otto; Edith Olah
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

7.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

8.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

9.  Population carrier frequency of hMSH2 and hMLH1 mutations.

Authors:  M G Dunlop; S M Farrington; I Nicholl; L Aaltonen; G Petersen; M Porteous; A Carothers
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.

Authors:  Sharon E Plon; Diana M Eccles; Douglas Easton; William D Foulkes; Maurizio Genuardi; Marc S Greenblatt; Frans B L Hogervorst; Nicoline Hoogerbrugge; Amanda B Spurdle; Sean V Tavtigian
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more
  107 in total

Review 1.  Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.

Authors:  Douglas M Banda; Nicole N Nuñez; Michael A Burnside; Katie M Bradshaw; Sheila S David
Journal:  Free Radic Biol Med       Date:  2017-01-10       Impact factor: 7.376

2.  Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome.

Authors:  Jonathan W Wischhusen; Chinedu Ukaegbu; Tara G Dhingra; Hajime Uno; Fay Kastrinos; Sapna Syngal; Matthew B Yurgelun
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-15       Impact factor: 4.254

Review 3.  Recent advances in Lynch syndrome.

Authors:  Leah H Biller; Sapna Syngal; Matthew B Yurgelun
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

4.  SEOM clinical guideline on hereditary colorectal cancer (2019).

Authors:  C Guillén-Ponce; E Lastra; I Lorenzo-Lorenzo; T Martín Gómez; R Morales Chamorro; A B Sánchez-Heras; R Serrano; M C Soriano Rodríguez; J L Soto; L Robles
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

5.  Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.

Authors:  Helle Vendel Petersen; Birgitte Lidegaard Frederiksen; Charlotte Kvist Lautrup; Lars Joachim Lindberg; Steen Ladelund; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

6.  Age dependency of the polygenic risk score for colorectal cancer.

Authors:  Shuai Li; John L Hopper
Journal:  Am J Hum Genet       Date:  2021-03-04       Impact factor: 11.025

7.  Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.

Authors:  Carin R Espenschied; Holly LaDuca; Shuwei Li; Rachel McFarland; Chia-Ling Gau; Heather Hampel
Journal:  J Clin Oncol       Date:  2017-05-17       Impact factor: 44.544

8.  Germline Genetic Features of Young Individuals With Colorectal Cancer.

Authors:  Elena M Stoffel; Erika Koeppe; Jessica Everett; Peter Ulintz; Mark Kiel; Jenae Osborne; Linford Williams; Kristen Hanson; Stephen B Gruber; Laura S Rozek
Journal:  Gastroenterology       Date:  2017-11-14       Impact factor: 22.682

Review 9.  Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.

Authors:  Laura Valle; Eduardo Vilar; Sean V Tavtigian; Elena M Stoffel
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

10.  Lynch Syndrome-Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank.

Authors:  Rachel E Rosenblum; Celina Ang; Sabrina A Suckiel; Emily R Soper; Meenakshi R Sigireddi; Sinead Cullina; Gillian M Belbin; Aimee L Lucas; Eimear E Kenny; Noura S Abul-Husn
Journal:  JCO Precis Oncol       Date:  2020-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.